دورية أكاديمية

Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring

التفاصيل البيبلوغرافية
العنوان: Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring
المؤلفون: Klonoff, David C., Gabbay, Monica, Moon, Sun Joon, Wilmot, Emma G.
المساهمون: Abbott Diabetes Care
المصدر: Journal of Diabetes Science and Technology ; ISSN 1932-2968 1932-2968
بيانات النشر: SAGE Publications
سنة النشر: 2024
الوصف: Continuous glucose monitoring (CGM) has been shown to improve glycemic control and self-monitoring, as well as to reduce the risk of hypoglycemia. Integrated CGM (iCGM) FDA-cleared systems with published performance data are established nonadjunctive and accurate CGM tools that can directly inform decision-making in the treatment of diabetes (i.e., insulin dosing). Studies have assessed accuracy and safety data of CGMs that were eventually cleared for iCGM by the FDA and that informed the recommendation for their nonadjunctive use. Subsequent robust clinical trials and real-world studies demonstrated clinical effectiveness with improvements in a range of patient outcomes. In recent years, a number of non-iCGM-approved CGM devices have entered the market outside the United States worldwide. Some of these non-iCGM-approved CGM devices require additional user verification of blood glucose levels to be performed for making treatment decisions, termed adjunctive. Moreover, in many non-iCGM-approved CGM devices, accuracy studies published in peer-reviewed journals are scarce or have many limitations. Consequently, non-iCGM-approved CGM devices cannot be automatically perceived as having the same performance or quality standards than those approved for iCGM by the FDA. As a result, although these devices tend to cost less than iCGMs that carry FDA clearance and could therefore be attractive from the point of view of a health care payer, it must be emphasized that evaluation of costs should not be limited to the device (such as the usability preference that patients have for nonadjunctive sensors compared to adjunctive sensors) but to the wider value of the total benefit that the product provides to the patient.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1177/19322968241250357
الإتاحة: https://doi.org/10.1177/19322968241250357Test
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.B59DCD51
قاعدة البيانات: BASE